The U.S. Food and Drug Administration has been pushing nicotine pouch manufacturers to adopt child-resistant packaging since September 2025, when poison-center data showed that 72 percent of reported pouch exposure cases involved children under 5. All 20 FDA-authorized pouch products already use it. But for the hundreds of pouch brands whose cans were designed without child-resistant closures, adding one has meant a choice between expensive redesigns or regulatory risk.

A new product from Chemular, launched on 17 August 2026, is built to change that math.

The Safeguard Mark I is a patent-pending external sleeve that snaps onto an existing nicotine pouch can and locks with a proprietary spring-based mechanism. It does not require manufacturers to redesign their cans, replace manufacturing infrastructure, or — critically — disrupt premarket tobacco product applications (PMTAs) already under FDA review.

Why child-safe packaging matters

Nicotine pouches contain concentrated nicotine that can be harmful or potentially fatal to young children, even in small amounts. The FDA has reported toxic effects in young children at nicotine doses as low as 1 to 4 milligrams — a range that many single pouches exceed. Symptoms of nicotine poisoning include confusion, vomiting, and loss of consciousness.

Between April 2022 and March 2025, the number of nicotine pouch exposure cases reported to U.S. Poison Centers steadily increased. The fruity flavours and bright packaging that drive adult sales also make pouches attractive to children. "The fruity flavors and bright, colorful designs of nicotine pouch products could resemble candy and seem attractive to children," FDA Commissioner Marty Makary said when the agency issued its guidance.

The regulatory stakes have only grown. Under FDA enforcement guidance issued in May 2026, the agency said it may consider whether a product lacks child-resistant packaging when deciding which unauthorized nicotine pouches to target for enforcement. Packaging has also played a role in authorisation decisions: the FDA highlighted ZYN's certified child-resistant polypropylene cans and safety lids when it authorised those products, and noted the same for the six on! PLUS pouches authorised through its accelerated review pilot.

The PMTA problem

For manufacturers with pending PMTA applications, the packaging question creates a trap. Changing a product's primary container can constitute a product modification — one that may require updating a pending application or, in the worst case, restarting the regulatory process.

That is the problem Chemular designed Safeguard to solve. Rather than replacing the can, Safeguard surrounds it. The clear outer architecture preserves existing labels, branding, and scannable UPC barcodes. A single application station on the production line is enough to add the component across multiple can formats.

"Every brand out there is trying to solve the same problem," said Jason Carignan, Chief Commercial Officer of Chemular. "How do you implement child-resistant packaging without starting over or incurring significant costs?"

The intellectual-property landscape adds another wrinkle. Existing packaging patents can limit the options available to manufacturers seeking child-resistant cans. Chemular says Safeguard's external architecture and proprietary locking system offer an alternative that sidesteps some of those constraints.

What's next

Chemular has not disclosed pricing or identified customers. The company said it is working with brands and manufacturers evaluating Safeguard for both existing and new nicotine pouch products.

The launch comes at a moment when child-resistant packaging is moving from recommendation to expectation. The FDA's PMTA pilot programme has made CRC a visible factor in authorisation decisions. Its enforcement guidance treats the absence of CRC as a potential safety red flag. And the poison-control data that prompted the original FDA warning has not improved — the trend was described as "steadily increasing" when the agency last updated the figures.

For an industry where most cans were designed before child resistance was on the regulatory agenda, a retrofit that preserves existing packaging, branding, and regulatory investment is a practical shortcut. Whether manufacturers adopt it at scale will depend on cost, compatibility, and whether the FDA's "may consider" language on enforcement hardens into a requirement.

---

Compare nicotine pouch brands and prices at PouchFinder.

SOURCES:

• Chemular, "Chemular Launches Safeguard™, A New Universal Approach to Child-Resistant Nicotine Pouch Packaging." 17 Aug 2026. PRNewswire
• Tobacco Reporter, "Chemular Launches Child-Resistant Packaging for Nicotine Pouches." 17 Aug 2026. Tobacco Reporter
• Nicotine Insider, "Chemular Debuts CRC Nicotine Pouch System." 17 Aug 2026. Nicotine Insider
• FDA, "FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging Following Increasing Reports of Accidental Exposure." 2 Sept 2025. FDA